SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Interim Management Statement

9 May 2013 07:00

RNS Number : 2866E
Tullett Prebon PLC
09 May 2013
 

9 May 2013

 

Tullett Prebon plc

 

AGM Statement and Interim Management Statement

 

Tullett Prebon plc (the "Company") is today issuing its Interim Management Statement in relation to the period from 1 January 2013. This statement will be delivered to those attending the Annual General Meeting today.

 

Business Update

 

As expected, market conditions have continued to be challenging. The level of activity in the world's financial markets has remained subdued reflecting persistently low volatility. Market volumes also continue to be adversely affected by the more onerous regulatory environment applicable to many of our customers, and by the considerable uncertainty over the impact of new regulations covering the OTC markets, both of which reduce our customers' ability and willingness to trade.

 

Revenue in the four months to April was £293m, 4% lower than reported for the equivalent period last year. At constant exchange rates revenue was also 4% lower.

 

The business has continued to develop its hybrid electronic broking offering to comply with regulatory requirements and to respond to market demand. We are well prepared for the implementation in the USA of the rules relating to swap and security-based swap execution facilities, and we intend to launch platforms in the USA for those products which are within the scope of the rules after those rules have been published in final form.

 

We have recently finalised the terms of a participation agreement under which a minimum of 12 leading banks will supply electronic streaming liquidity for Euro interest rate derivatives through tpSWAPDEAL, our interest rate swap platform.

 

Legal action continues to be pursued against BGC and former employees in the USA in response to the raid on the business by BGC in the second half of 2009. The FINRA arbitration on the claim brought by the subsidiary companies in the United States directly affected by the raid is expected to continue through the first half of this year. The outcome of the arbitration is expected to be determined before the end of the year. A separate action is being pursued by the Company and the directly affected subsidiaries in the New Jersey Superior Court, alleging, among other causes of action, violations under the NJ RICO Act. Discovery is ongoing and no trial date has been set. Since 1 January, £6.8m of costs have been incurred in relation to these actions. Consistent with the treatment adopted in 2012, these costs will be recognised as an exceptional charge in the 2013 accounts.

 

On 19 April the Company entered into a new three year £150m revolving credit facility replacing the previous bank facilities. All the outstanding bank term debt under the previous facility has now been repaid. The Company's financial position remains strong.

 

 

 

Enquiries:

 

Nigel Szembel, Head of Communications, Tullett Prebon plc

Direct: +44 (0)20 7200 7722

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBLGDUIGGBGXI
Date   Source Headline
17th May 20235:05 pmRNSResult of AGM
17th May 20237:00 amRNSTrading Statement
13th Apr 202312:30 pmRNSHolding(s) in Company
5th Apr 20233:00 pmRNSDirector/PDMR Shareholding
4th Apr 202311:00 amRNSNotice of AGM and Committee Membership Changes
3rd Apr 20235:05 pmRNSDirector/PDMR Shareholding
29th Mar 20234:00 pmRNSHolding(s) in Company
23rd Mar 202311:00 amRNSDirector/PDMR Shareholding
22nd Mar 202311:00 amRNS2022 Annual Report and Accounts
14th Mar 20237:00 amRNSTP ICAP Group PLC - Final Results
8th Feb 20234:19 pmRNSChanges to Senior Independent Director
13th Dec 202210:00 amRNSHolding(s) in Company
6th Dec 20225:15 pmRNSHolding(s) in Company
1st Nov 20227:00 amRNSTrading Statement
27th Oct 20225:30 pmRNSHolding(s) in Company
25th Oct 20225:50 pmRNSHolding(s) in Company
13th Sep 20225:32 pmRNSHolding(s) in Company
10th Aug 20227:00 amRNSHalf-year Report
28th Jul 20225:22 pmRNSResult of External Audit Tender
30th Jun 20225:44 pmRNSHolding(s) in Company
27th May 20223:30 pmRNSDirector/PDMR Shareholding
11th May 20226:01 pmRNSResult of AGM
11th May 20227:00 amRNSTrading Statement
4th May 20224:27 pmRNSGrant of Options and Director/PDMR Shareholding
22nd Apr 20224:49 pmRNSHolding(s) in Company
11th Apr 20224:17 pmRNSHolding(s) in Company
5th Apr 202211:02 amRNSAnnual Financial Report
4th Apr 20224:03 pmRNSDirector/PDMR Shareholding
31st Mar 20226:03 pmRNSDirector/PDMR Shareholding
29th Mar 20225:44 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSFinal Results
11th Jan 202211:35 amRNSHolding(s) in Company
22nd Dec 20215:00 pmRNSAppointment of new director
13th Dec 20213:24 pmRNSDirector/PDMR Shareholding
12th Nov 20212:04 pmRNSShareholder meeting update and PDMR transactions
12th Nov 20211:57 pmRNSTotal Voting Rights
2nd Nov 20217:00 amRNSTrading update - three months ended 30/09/2021
11th Oct 20214:00 pmRNSDirector/PDMR Shareholding
11th Oct 20213:01 pmRNSParameta Solutions Investor Seminar
7th Oct 202110:40 amRNSDirector/PDMR Shareholding
20th Sep 20214:58 pmRNSDirector/PDMR Shareholding
8th Sep 20215:08 pmRNSDirector/PDMR Shareholding
7th Sep 20217:00 amRNSHalf-year Report
3rd Aug 20217:00 amRNSTrading Statement
22nd Jun 20214:36 pmRNSDirector/PDMR Shareholding
18th May 202111:20 amRNSDirector/PDMR Shareholding
12th May 20215:49 pmRNSResult of AGM
12th May 20217:00 amRNSTrading Statement
23rd Apr 20215:10 pmRNSGrant of Options and Director/PDMR Shareholding
6th Apr 20214:32 pmRNSDirector/PDMR Shareholding - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.